RLMD
Relmada Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Relmada Therapeutics (RLMD) Stock: Buy, Sell, or Hold?
$4.43
+0.16 (+3.75%)
▲
5d:
+6.24%
30d:
+31.85%
90d:
-6.74%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$3.14 – $3.92
Position: EXTENDED
Forward P/E & Valuation
-10.8x
Next 12M consensus est.
Wall Street Target
$10.75
+142.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.29 / $4.60
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: RLMD is 13.0% above its trading range ($3.92). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $4.43, which is considered extended relative to its 30-day fair value range of $3.14 to $3.92.
Technical Outlook: Technically, RLMD is in a strong downtrend. Immediate support is located at $3.29, while resistance sits at $4.60. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: RLMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.75 (+142.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RLMD is in a strong downtrend. Immediate support is located at $3.29, while resistance sits at $4.60. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: RLMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.75 (+142.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.14 -
$3.92
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$3.14 -
$3.92
Current vs Trading Range
EXTENDED
Support Level
$3.29
Resistance Level
$4.60
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+13.0% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 142.7% below Wall St target ($10.75)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-10.80
Wall Street Target
$10.75
(+142.7%)
Share RLMD Analysis
Share this live RLMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RLMD)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Relmada Therapeutics announced participation in the Jefferies Global Healthcare Conference in London, with management available for one-on-one meetings.
Key Retail Themes:
Company Participation in Conferences
Investor Relations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:44 PM ET
Data refreshes hourly during market hours. Next update: 8:44 PM
Data refreshes hourly during market hours. Next update: 8:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RLMD Research Pages
